CN103468595B - 表达重组人血白蛋白的酵母菌、其构建方法及应用和表达重组人血白蛋白的方法 - Google Patents
表达重组人血白蛋白的酵母菌、其构建方法及应用和表达重组人血白蛋白的方法 Download PDFInfo
- Publication number
- CN103468595B CN103468595B CN201310441524.XA CN201310441524A CN103468595B CN 103468595 B CN103468595 B CN 103468595B CN 201310441524 A CN201310441524 A CN 201310441524A CN 103468595 B CN103468595 B CN 103468595B
- Authority
- CN
- China
- Prior art keywords
- pichia pastoris
- serum albumin
- human serum
- plasmid
- monoploid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000008100 Human Serum Albumin Human genes 0.000 title claims abstract description 105
- 108091006905 Human Serum Albumin Proteins 0.000 title claims abstract description 105
- 238000000034 method Methods 0.000 title claims abstract description 66
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 23
- 238000010276 construction Methods 0.000 title abstract description 9
- 230000008569 process Effects 0.000 title abstract description 9
- 241000235058 Komagataella pastoris Species 0.000 claims abstract description 122
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 51
- 108091026890 Coding region Proteins 0.000 claims abstract description 47
- 229920001184 polypeptide Polymers 0.000 claims abstract description 45
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 45
- 241000894006 Bacteria Species 0.000 claims abstract description 42
- 230000013011 mating Effects 0.000 claims abstract description 24
- 239000013612 plasmid Substances 0.000 claims description 69
- 108090000623 proteins and genes Proteins 0.000 claims description 49
- 239000013604 expression vector Substances 0.000 claims description 42
- 238000012216 screening Methods 0.000 claims description 37
- 108010084455 Zeocin Proteins 0.000 claims description 28
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 claims description 28
- 101100379633 Xenopus laevis arg2-a gene Proteins 0.000 claims description 24
- 101150088826 arg1 gene Proteins 0.000 claims description 24
- 108091008146 restriction endonucleases Proteins 0.000 claims description 22
- 101150043924 metXA gene Proteins 0.000 claims description 18
- 108020004414 DNA Proteins 0.000 claims description 17
- 238000012360 testing method Methods 0.000 claims description 17
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 14
- 230000015572 biosynthetic process Effects 0.000 claims description 14
- 238000003786 synthesis reaction Methods 0.000 claims description 14
- 238000000855 fermentation Methods 0.000 claims description 13
- 230000004151 fermentation Effects 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 239000012634 fragment Substances 0.000 claims description 9
- 239000001888 Peptone Substances 0.000 claims description 8
- 108010080698 Peptones Proteins 0.000 claims description 8
- 235000019319 peptone Nutrition 0.000 claims description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 7
- 230000037361 pathway Effects 0.000 claims description 6
- 239000004475 Arginine Substances 0.000 claims description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 5
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 5
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 claims description 5
- 229930182817 methionine Natural products 0.000 claims description 5
- 238000012408 PCR amplification Methods 0.000 claims description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 4
- 101000807603 Caenorhabditis elegans Orotidine 5'-phosphate decarboxylase Proteins 0.000 claims description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 claims description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 3
- 101150044776 URA5 gene Proteins 0.000 claims description 3
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- 101150029559 hph gene Proteins 0.000 claims description 3
- 230000010354 integration Effects 0.000 claims 9
- 239000012467 final product Substances 0.000 claims 4
- 108010045123 Blasticidin-S deaminase Proteins 0.000 claims 2
- 238000009776 industrial production Methods 0.000 claims 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000012163 sequencing technique Methods 0.000 description 15
- 108010076504 Protein Sorting Signals Proteins 0.000 description 14
- 239000002609 medium Substances 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 150000007523 nucleic acids Chemical group 0.000 description 13
- 230000001580 bacterial effect Effects 0.000 description 12
- 239000003292 glue Substances 0.000 description 11
- 238000012797 qualification Methods 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 238000000246 agarose gel electrophoresis Methods 0.000 description 10
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical group C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 9
- 230000003321 amplification Effects 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 238000003259 recombinant expression Methods 0.000 description 8
- 230000002950 deficient Effects 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 102100036826 Aldehyde oxidase Human genes 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 6
- 102000007562 Serum Albumin Human genes 0.000 description 6
- 108010071390 Serum Albumin Proteins 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 5
- 229930003756 Vitamin B7 Natural products 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 239000011735 vitamin B7 Substances 0.000 description 5
- 235000011912 vitamin B7 Nutrition 0.000 description 5
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 4
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000010836 blood and blood product Substances 0.000 description 3
- 229940125691 blood product Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 108010026552 Proteome Proteins 0.000 description 2
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 239000006052 feed supplement Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229940093916 potassium phosphate Drugs 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012882 sequential analysis Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 101150006240 AOX2 gene Proteins 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101001079065 Homo sapiens Ras-related protein Rab-1A Proteins 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 101100502336 Komagataella pastoris FLD1 gene Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 101150005314 PEX8 gene Proteins 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 102100028191 Ras-related protein Rab-1A Human genes 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 101100421128 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SEI1 gene Proteins 0.000 description 1
- 241000203644 Streptoalloteichus hindustanus Species 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 229930189065 blasticidin Natural products 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000001142 circular dichroism spectrum Methods 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002016 colloidosmotic effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 210000003783 haploid cell Anatomy 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 238000009955 starching Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 231100000033 toxigenic Toxicity 0.000 description 1
- 230000001551 toxigenic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 235000000112 undernutrition Nutrition 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Abstract
Description
Claims (24)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310441524.XA CN103468595B (zh) | 2013-09-24 | 2013-09-24 | 表达重组人血白蛋白的酵母菌、其构建方法及应用和表达重组人血白蛋白的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310441524.XA CN103468595B (zh) | 2013-09-24 | 2013-09-24 | 表达重组人血白蛋白的酵母菌、其构建方法及应用和表达重组人血白蛋白的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103468595A CN103468595A (zh) | 2013-12-25 |
CN103468595B true CN103468595B (zh) | 2016-01-13 |
Family
ID=49793638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310441524.XA Active CN103468595B (zh) | 2013-09-24 | 2013-09-24 | 表达重组人血白蛋白的酵母菌、其构建方法及应用和表达重组人血白蛋白的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103468595B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106220726A (zh) * | 2016-05-25 | 2016-12-14 | 西北民族大学 | 重组人血白蛋白及其表达载体的构建方法 |
CN111662944A (zh) * | 2019-03-05 | 2020-09-15 | 上海医药工业研究院 | 一种人血清白蛋白的制备方法及其纯化方法 |
CN110862934A (zh) * | 2019-12-31 | 2020-03-06 | 扬中酵诚生物技术研究有限公司 | 毕赤酵母高密度培养基及其制作工艺 |
CN113201464B (zh) * | 2020-12-30 | 2023-01-20 | 广东省科学院生物工程研究所 | 一株产α-葡聚糖酶的毕赤酵母工程菌及其构建方法、培养方法与应用 |
CN113528566B (zh) * | 2021-06-03 | 2022-12-20 | 自然资源部第三海洋研究所 | 一种酵母菌重组表达载体及其构建方法与应用 |
CN116134050A (zh) * | 2022-09-02 | 2023-05-16 | 通化安睿特生物制药股份有限公司 | 一种提高重组人白蛋白表达量的方法和细胞和蛋白 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8709756B2 (en) * | 2003-10-22 | 2014-04-29 | Keck Graduate Institute | Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
-
2013
- 2013-09-24 CN CN201310441524.XA patent/CN103468595B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8709756B2 (en) * | 2003-10-22 | 2014-04-29 | Keck Graduate Institute | Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
Non-Patent Citations (4)
Title |
---|
Generation of diploid pichia pastoris strains by mating and their application for recombinant protein production;Chen et al;《Microbial Cell Factories》;20120702;1-18 * |
提高外源基因在巴斯德毕赤酵母中表达量的研究进展;肖生科 等;《生物技术通报》;20040229(第2期);23-27 * |
表达乙肝病毒融合表面抗原基因SA-28的二倍体酵母工程菌的选育;陈孝康 等;《生物工程学报》;20000131;第16卷(第1期);10-12 * |
重组人血清白蛋白在酵母中的表达及分析鉴定;陈琳 等;《军事医学科学院院刊》;20010930;第25卷(第3期);202-204 * |
Also Published As
Publication number | Publication date |
---|---|
CN103468595A (zh) | 2013-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103468595B (zh) | 表达重组人血白蛋白的酵母菌、其构建方法及应用和表达重组人血白蛋白的方法 | |
CN101492661B (zh) | 一种β-葡萄糖苷酶基因的克隆、表达及用于龙胆低聚糖的制备 | |
EP3536792A1 (en) | Recombinant yeast and use thereof | |
CN110157654B (zh) | 一种纳豆芽孢杆菌重组菌及其构建方法与应用 | |
KR20190018724A (ko) | 피치아 파스토리스 발현 재조합 단백질의 발효 공법 | |
CN102439154A (zh) | 一种多核苷酸和多肽链序列及其方法 | |
CN101974587A (zh) | 一种高效表达人血清白蛋白的方法 | |
CN101665798B (zh) | 一种制备重组人血清白蛋白与干扰素α融合蛋白的方法 | |
CN107778365B (zh) | 一种多点整合的重组蛋白表达方法 | |
WO2023221787A1 (zh) | 重组i型胶原蛋白毕赤酵母工程菌及其构建方法与应用 | |
CN102559730B (zh) | 一种提高cp4-epsps在汉逊酵母中表达量的方法 | |
CN102433265A (zh) | 生产还原型谷胱甘肽的重组菌株及其制备方法 | |
CN105002103A (zh) | 一种重组g-csf(15-75)多肽毕赤酵母菌的发酵方法 | |
CN102898512B (zh) | 一种重组菌丝霉素及其制备方法和用途 | |
US20230220358A1 (en) | Nucleic Acids, Vectors, Host Cells and Methods for Production of Fructosyltransferase from Aspergillus Japonicus | |
CN112522125B (zh) | 一种透明质酸酶工程菌及其构建方法与应用 | |
CN111909859B (zh) | 一种巴斯德毕赤酵母低温型培养基 | |
CN102911886A (zh) | 利用毕赤酵母基因调控直接发酵制备一种抗肿瘤药物复合物的方法 | |
CN102533841B (zh) | 一种提高Bt杀虫蛋白在汉逊酵母中表达量的方法 | |
CN102660568B (zh) | 一种重组胸腺肽α1的制备方法 | |
CN101649340A (zh) | 人白细胞介素18的制备方法 | |
CN110527690A (zh) | 一种耐热型单宁酶及其应用 | |
CN115838645B (zh) | 一种高产乳清酸的酵母菌株及其应用 | |
CN113493745B (zh) | 生产头孢菌素c的基因工程菌及其构建方法 | |
CN117903295A (zh) | 一种用于分泌表达乳铁蛋白的马克斯克鲁维酵母及其构建方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Yeast expressing recombinant human albumin, its construction method, application and method of expressing recombinant human albumin Effective date of registration: 20201226 Granted publication date: 20160113 Pledgee: Industrial Commercial Bank of China Ltd. Taizhou Jiaojiang branch Pledgor: ZHEJIANG HISUN PHARMACEUTICAL Co.,Ltd. Registration number: Y2020330001302 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210425 Granted publication date: 20160113 Pledgee: Industrial Commercial Bank of China Ltd. Taizhou Jiaojiang branch Pledgor: ZHEJIANG HISUN PHARMACEUTICAL Co.,Ltd. Registration number: Y2020330001302 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Yeast expressing recombinant human albumin, construction method and application thereof, and method for expressing recombinant human albumin Effective date of registration: 20210729 Granted publication date: 20160113 Pledgee: Industrial Commercial Bank of China Ltd. Taizhou Jiaojiang branch Pledgor: ZHEJIANG HISUN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021330000982 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230130 Granted publication date: 20160113 Pledgee: Industrial Commercial Bank of China Ltd. Taizhou Jiaojiang branch Pledgor: ZHEJIANG HISUN PHARMACEUTICAL Co.,Ltd. Registration number: Y2021330000982 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Yeast expressing recombinant human serum albumin, its construction method, application and expression method Effective date of registration: 20230228 Granted publication date: 20160113 Pledgee: Industrial Commercial Bank of China Ltd. Taizhou Jiaojiang branch Pledgor: ZHEJIANG HISUN PHARMACEUTICAL Co.,Ltd. Registration number: Y2023330000447 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |